GuideMia Technologies Secures RMB 10 Million in Angel Funding to Advance Digital Dentistry Solutions
VCBeat (WeChat: vcbeat) has learned that in September last year, GuideMia Technologies (hereinafter referred to as “GaiMei Tech”), a tech-innovation enterprise in the digital dentistry sector previously reported on, announced the completion of its RMB 10 million angel financing round.The investor is the CAS Jiahe Fund, a fund within the Chinese Academy of Sciences system that focuses on the commercialization of high-tech achievements.。
The proceeds from this round of financing will be used to promote implantology and orthodontic software, as well as surgical guides and aligners; to prepare for expanding the company’s business scope and introducing new products; and to intensify product promotion in international markets.
Currently, consumption upgrades are driving growing public attention to oral health issues. However, as a traditional sector within the healthcare industry, dentistry faces a critical bottleneck in its development: a severe shortage of dental professionals.
Compared with developed countries, China's dental industry shows a significant gap.The Chinese Stomatological Association has been focusing on the promotion of digitalization in recent years, based on its understanding of the current state of the industry.. Empowering dentistry with digital technology is the core objective of this medical technology company, among whichDigital Implantology and Orthodontics Are the Key to Breaking Through Industry Bottlenecks。
GuideMia Technologies, established in California, USA, in 2012, is dedicated to the research and development of products in the field of digital dentistry as well as the promotion of digital concepts. Founded by Dr. Gao Fei, a technical expert in digital dentistry, the company boasts a senior R&D team with over 20 years of experience in CAD/CAM and medical image processing. By bringing together top clinical dental experts from both China and abroad, GuideMia Technologies is committed to building a leading digital dentistry platform.
Dr. Gao Fei, the founder, is a postdoctoral fellow from Shanghai Jiao Tong University and a Humboldt Scholar. He previously worked at Siemens PLM, where he was responsible for the system architecture of CAD/CAM software, and at Glidewell, the largest dental laboratory and denture manufacturing facility in the United States, where he led software R&D. This cross-industry experience has endowed him with unique insights and expertise at the intersection of dentistry and digitalization.
The company primarily focuses on digital implantology and orthodontics, providing core technologies, services, platforms, as well as supporting equipment and consumables, thereby pioneering a new integrated model that combines technology, laboratory services, clinical practice, and platform solutions.
VCBeat (WeChat: vcbeat) has learned that the company’s products have obtained U.S. FDA clearance and European CE certification, hold multiple technical patents, and that the company established a new entity in Shanghai in 2016.
One of the products maximizes support for precise and minimally invasive implant placement in clinical practice, fundamentally alleviating the concerns and suffering of patients requiring dental implants, shortening recovery time, and enhancing surgical safety. Leveraging this digital technology also significantly reduces the time required for clinicians to develop into experienced implant specialists.
This round of financing has provided the company with full momentum, leveraging its years of clinical accumulation and technological reserves to accelerate its expansion into broader domestic and international markets in digital dentistry.
Guoke Jiahe Fund is an equity investment fund manager initiated by CAS Holdings Co., Ltd. as the cornerstone investor and established in collaboration with multiple large domestic enterprise groups. It serves as an investment platform directly managed by CAS Holdings, with total assets under management amounting to tens of billions of RMB.
Leveraging the Chinese Academy of Sciences’ world-class technological capabilities, extensive portfolio of commercialized high-tech achievements, and government and industry resources, as well as its rich investment management experience and professional team, Guoke Jiahe focuses on emerging sectors such as Information Technology (TMT), healthcare, and life sciences. The firm prioritizes investments in early-stage and growth-stage high-tech innovative enterprises with strong technological barriers.
Chen Hongwu, Managing Partner at CAS Star Capital, stated, “The dental digitalization market in China is still in its early stages. Gaimi Technology has developed its own core software solutions for surgical guides and orthodontic treatment planning, featuring globally leading technology. Its products, initially launched in European and American markets, have now entered the Chinese market and gained recognition among dentists, filling a gap in this field in China. The team possesses strong independent R&D capabilities and offers a complete product portfolio in dental digitalization, which were key factors in our investment decision. Thirty percent of CAS Star Capital’s funds are allocated to the healthcare sector, and Gaimi Technology represents another strategic move by the fund in the field of precision medicine.”
Regarding the support from CAS Star Capital, Dr. Gao Fei, the founder, stated: “We appreciate CAS Star Capital’s recognition of our current market positioning and future growth prospects. As digitalization in the dental industry deepens and expands, it is our historical mission to develop core technologies and products with independent intellectual property rights and to lead the international market. The task is arduous, and the road ahead is long. We believe that, with the boost from capital investment, our business will accelerate onto the fast track of development and make due contributions to transforming the dental industry through Chinese technology.”
For many years, Aimeike Technology has been dedicated to transforming user needs into high-quality technical solutions. Rooted in clinical practice and refined through it, our close collaboration with leading dental implant experts both in China and abroad has driven continuous iterations and upgrades of our software. This has evolved into a powerful product that closely aligns with clinicians’ needs, offering comprehensive and convenient support for clinical workflows.
Dr. Gao Fei stated, “We adhere to the philosophy of open systems, believing this to be the direction for our industry. We will intensify our investment in the research and development of new products and technologies, realizing the vision of ‘technology as a service, services on a platform, and platforms industrialized,’ and advancing lean digital transformation in the practice of precision dentistry and minimally invasive surgery.”
Further Reading: